- Portable molecular diagnostics devices, enabling rapid and accurate detection of diseases at the point of care, are becoming essential tools in modern healthcare settings. Their integration into clinical workflows enhances patient outcomes through timely decision-making and treatment initiation
- The escalating demand for these devices is primarily fueled by the rising prevalence of infectious diseases, the need for decentralized healthcare solutions, and advancements in molecular technologies that allow for miniaturization and automation of diagnostic processes
- North America dominates the portable molecular platforms market with the largest revenue share of 46.5% in 2024, characterized by region's advanced healthcare infrastructure, high adoption rates of innovative diagnostic tools, and the presence of key industry players
- Asia-Pacific is expected to be the fastest growing region in the portable molecular platforms market during the forecast period due to increasing healthcare investments, rising awareness of early disease detection, and the expansion of healthcare services in emerging economies
- Assays & Kits segment dominates the portable molecular platforms market with a market share of 53.2% in 2024, driven by its widespread use in rapid diagnostics and ease of integration into point-of-care testing environments
